Subjects: Data Analysis and United States / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Data Analysis ✖ Subjects United States ✖ Copyright Public domain ✖

1. COVID-19: HHS’s collection of hospital capacity data : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, August 2021
Subject(s):: COVID-19 -- economics
Data Analysis
Government Regulation
Surge Capacity -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

2. Medicare Advantage organizations are missing opportunities to use ordering provider identifiers to protect program integrity

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, April 2021
Subject(s):: Data Analysis
Fraud -- prevention & control
Government Regulation
Medical Order Entry Systems
Medicare Part C -- economics
United States
United States. Department of Health and Human Services

3. VA health care: Incomplete information hinders usefulness of market assessments for VA facility realignment : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, February 2022
Subject(s):: Capacity Building -- economics
Data Analysis
Government Regulation
Hospitals, Veterans
United States
United States. Department of Veterans Affairs

4. Medicare Part B drug payments: impact of price substitutions based on 2020 average sales prices

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Data Analysis
Drug Costs
Government Regulation
Medicare Part B
United States

5. A resource guide for using Medicare’s enrollment race and ethnicity data

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2023
Subject(s):: Data Analysis
Ethnicity
Government Regulation
Healthcare Disparities
Medicare
Racial Groups
Race Factors
United States

6. Some skin substitute manufacturers did not comply with new ASP reporting requirements

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2023
Subject(s):: Data Analysis
Government Regulation
Manufacturing Industry -- legislation & jurisprudence
Skin, Artificial
United States

7. CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2022
Subject(s):: COVID-19
Data Analysis
Healthcare Disparities
Public Reporting of Healthcare Data
United States
Centers for Disease Control and Prevention (U.S.)

8. Challenges with vaccination data hinder state and local immunization program efforts to combat COVID-19

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2023
Subject(s):: COVID-19 -- prevention & control
COVID-19 Vaccines
Data Accuracy
Data Analysis
Government Regulation
Immunization Programs
United States

9. Toolkit: analyzing telehealth claims to assess program integrity risks

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, April 2023
Subject(s):: Data Analysis
Fraud -- prevention & control
Government Regulation
Insurance Claim Review
Medicaid
Medicare
Telemedicine
United States

10. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.